In the first human clinical trial, four adult patients showed that the injection is helpful in the fight against aggressive and lethal brain tumors.
It is tailored to each patient’s DNA and uses technology akin to that of some Covid vaccines to train the immune system.
Dr. Elias Sayour, a researcher at the University of Florida, expressed optimism that this could be a new paradigm for how we treat patients and a new platform for technology that allows us to modify the immune system.
“I’m excited about the potential for this to now work in concert with other immunotherapies and possibly even unlock them.”
“We demonstrated that immunotherapies can work in concert with one another, so perhaps a combination approach to immunotherapy is now possible.”
During the pandemic, mRNA vaccines—like the COVID vaccinations from Pfizer and Moderna—became increasingly popular. Scientists are already applying this technique to other diseases.
They work by providing the body’s immune system with a genetic code to read, which prompts the immune system to make more attack cells.
